The trajectory of companies tied to blockbuster drugs like Viagra presents a complex investment scenario . While the initial surge of copyright, fueled by Viagra's remarkable popularity, generated substantial profits , the loss of exclusivity in key territories has introduced significant risk . Investors are now facing the consequences of rival med